Guangzhou Improve Med Instrument - Asset Resilience Ratio
Guangzhou Improve Med Instrument (300030) has an Asset Resilience Ratio of 4.20% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Guangzhou Improve Med Instrument (300030) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2014–2023)
This chart shows how Guangzhou Improve Med Instrument's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Guangzhou Improve Med Instrument (300030) total assets.
Liquid Assets Composition Over Time
This chart breaks down Guangzhou Improve Med Instrument's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore 300030 long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥43.00 Million | 4.2% |
| Total Liquid Assets | CN¥43.00 Million | 4.20% |
Asset Resilience Insights
- Limited Liquidity: Guangzhou Improve Med Instrument maintains only 4.20% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Guangzhou Improve Med Instrument Industry Peers by Asset Resilience Ratio
Compare Guangzhou Improve Med Instrument's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 7.53% |
|
Eyebright Medical Technology Beijing Co Ltd
SHG:688050 |
Medical Instruments & Supplies | 1.51% |
|
Andon Health Co Ltd
SHE:002432 |
Medical Instruments & Supplies | 18.11% |
|
Vizionfocus Inc.
TW:4771 |
Medical Instruments & Supplies | 3.24% |
|
Pro-Dex Inc
NASDAQ:PDEX |
Medical Instruments & Supplies | 1.39% |
|
Nyxoah
BR:NYXH |
Medical Instruments & Supplies | 12.40% |
|
Mark Dynamics Indonesia Tbk PT
JK:MARK |
Medical Instruments & Supplies | 6.64% |
|
Interojo Inc
KQ:119610 |
Medical Instruments & Supplies | 6.55% |
Annual Asset Resilience Ratio for Guangzhou Improve Med Instrument (2014–2023)
The table below shows the annual Asset Resilience Ratio data for Guangzhou Improve Med Instrument.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2023-12-31 | 1.61% | CN¥23.00 Million ≈ $3.37 Million |
CN¥1.43 Billion ≈ $208.66 Million |
+1.42pp |
| 2022-12-31 | 0.19% | CN¥3.00 Million ≈ $438.99K |
CN¥1.56 Billion ≈ $228.01 Million |
-2.91pp |
| 2020-12-31 | 3.10% | CN¥54.07 Million ≈ $7.91 Million |
CN¥1.74 Billion ≈ $255.31 Million |
-0.42pp |
| 2019-12-31 | 3.52% | CN¥53.00 Million ≈ $7.76 Million |
CN¥1.51 Billion ≈ $220.49 Million |
+3.06pp |
| 2018-12-31 | 0.45% | CN¥6.86 Million ≈ $1.00 Million |
CN¥1.51 Billion ≈ $221.13 Million |
+0.08pp |
| 2017-12-31 | 0.37% | CN¥6.53 Million ≈ $956.16K |
CN¥1.75 Billion ≈ $255.48 Million |
-- |
| 2016-12-31 | 0.00% | CN¥0.00 ≈ $0.00 |
CN¥1.47 Billion ≈ $215.09 Million |
-- |
| 2014-12-31 | 0.38% | CN¥3.90 Million ≈ $570.69K |
CN¥1.02 Billion ≈ $149.16 Million |
-- |
About Guangzhou Improve Med Instrument
Improve Medical Instruments Co., Ltd. engages in the provision of relevant technologies, products, and services for clinical laboratory and clinical nursing in China and internationally. It provides clinical laboratory products comprising feces and thrombosis viscoelastic analysis systems; and automatic biosafety decappers; and Q-VELOX, an intelligent molecular diagnostic workstation. The company… Read more